IP-10/MIG receptor designated CXCR3, nucleic acids, and methods of use therefor
US6686175B1 · kind B1 · utility
6Cited by
4References
44Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 25, 2000 |
| Grant date | Feb 3, 2004 |
| Priority date | — |
| Expiry date | Jul 25, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to isolated and/or recombinant nucleic acids encoding a mammalian (e.g., human) CXCR3 protein and variants thereof, including antisense nucleic acid, recombinant nucleic acid constructs, such as plasmids or retroviral vectors, comprising a nucleic acid which encodes a protein of the present invention or variant thereof, and to host cells comprising a nucleic acid or construct, useful in the production of recombinant proteins. The invention also relates to a method for producing a mammalian (e.g., human) CXCR3 protein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.